Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATTU
5201
DELISTED
Attunity Ltd
ATTU
| $138K | ﹤0.01% |
7,300
-1,364
| -16% | -$23.2K |
|
|
CPRX
5202
DELISTED
Catalyst Pharmaceutical
CPRX
| $137K | ﹤0.01% |
36,159
+29,093
| +412% | +$91.1K |
|
5203
McEwen Inc
MUX
$1.17B
| $137K | ﹤0.01% |
7,089
+1,070
| +18% | +$22.4K |
|
5204
CALL
Ferrari
RACE
$72.1B
| $137K | ﹤0.01% |
+1,000
| New | +$132K |
|
5205
CALL
Teradyne
TER
$59.3B
| $137K | ﹤0.01% |
3,700
+500
| +16% | +$20.1K |
|
5206
Turning Point Brands
TPB
$1.77B
| $137K | ﹤0.01% |
3,315
+2,737
| +474% | +$96.2K |
|
5207
CALL
Corpay
CPAY
$26.7B
| $137K | ﹤0.01% |
600
+300
| +100% | +$65.5K |
|
5208
New Mountain Finance
NMFC
$730M
| $136K | ﹤0.01% |
10,002
-5,794
| -37% | -$80.2K |
|
5209
POSCO
PKX
$17.3B
| $136K | ﹤0.01% |
2,065
| – | – |
|
5210
Sonos
SONO
$1.78B
| $136K | ﹤0.01% |
+8,505
| New | +$150K |
|
|
ZYNE
5211
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $136K | ﹤0.01% |
16,672
+1,272
| +8% | +$9.76K |
|
5212
Barings BDC
BBDC
$975M
| $135K | ﹤0.01% |
+13,472
| New | +$148K |
|
5213
PUT
BGC Group
BGC
$4.83B
| $135K | ﹤0.01% |
17,727
-7,464
| -30% | -$55.2K |
|
|
EBTC
5214
DELISTED
Enterprise Bancorp
EBTC
| $135K | ﹤0.01% |
3,943
+2,815
| +250% | +$103K |
|
5215
PUT
Cedar Fair
FUN
$1.63B
| $135K | ﹤0.01% |
2,600
+1,700
| +189% | +$94K |
|
5216
PUT
Lazard
LAZ
$4.24B
| $135K | ﹤0.01% |
2,800
+1,700
| +155% | +$84.5K |
|
5217
CALL
ProShares UltraShort QQQ
QID
$251M
| $135K | ﹤0.01% |
191
-140
| -42% | -$105K |
|
5218
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
| $135K | ﹤0.01% |
900
| – | – |
|
|
MR
5219
DELISTED
Montage Resources Corporation Common Stock
MR
| $135K | ﹤0.01% |
7,607
+7,052
| +1,271% | +$161K |
|
5220
PUT
Compass Minerals
CMP
$1.13B
| $134K | ﹤0.01% |
2,000
-1,100
| -35% | -$71.7K |
|
5221
Digimarc Corp
DMRC
$172M
| $134K | ﹤0.01% |
4,250
+3,430
| +418% | +$101K |
|
5222
Larimar Therapeutics
LRMR
$448M
| $134K | ﹤0.01% |
953
+812
| +576% | +$98.6K |
|
5223
PUT
Pentair
PNR
$10.7B
| $134K | ﹤0.01% |
3,100
-2,600
| -46% | -$113K |
|
5224
Travelzoo
TZOO
$73.2M
| $134K | ﹤0.01% |
11,368
-9,631
| -46% | -$137K |
|
|
FLG
5225
PUT
Flagstar Bank National Association
FLG
$5.89B
| $134K | ﹤0.01% |
4,300
-500
| -10% | -$16.4K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.